UBS Group’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $5K | Sell |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $9K | Sell |
|
|||||
|
2021
Q4 | $2.97M | Buy |
|
|||||
|
2021
Q3 | $4.23M | Buy |
|
|||||
|
2021
Q2 | $1.73M | Sell |
|
|||||
|
2021
Q1 | $3.86M | Buy |
|
|||||
|
2020
Q4 | $1.27M | Buy |
|
|||||
|
2020
Q3 | $1.49M | Buy |
|
|||||
|
2020
Q2 | $1.43M | Buy |
|
|||||
|
2020
Q1 | $974K | Buy |
|
|||||
|
2019
Q4 | $394K | Sell |
|
|||||
|
2019
Q3 | $3.64M | Buy |
|
|||||
|
2019
Q2 | $10.6M | Buy |
|
|||||
|
2019
Q1 | $629K | Sell |
|
|||||
|
2018
Q4 | $6.2M | Buy |
|
|||||
|
2018
Q3 | $930K | Sell |
|
|||||
|
2018
Q2 | $2.27M | Sell |
|
|||||
|
2018
Q1 | $6.47M | Buy |
|
|||||
|
2017
Q4 | $4.78M | Sell |
|
|||||
|
2017
Q3 | $6.58M | Buy |
|
|||||
|
2017
Q2 | $3.45M | Buy |
|
|||||
|
2017
Q1 | $402K | Sell |
|
|||||
|
2016
Q4 | $3.24M | Buy |
|
|||||
|
2016
Q3 | $2.25M | Sell |
|
|||||
|
2016
Q2 | $1.54M | Buy |
|
|||||
|
2016
Q1 | $117K | Sell |
|
|||||
|
2015
Q4 | $2.44M | Buy |
|
|||||
|
2015
Q3 | $5.33M | Buy |
|
|||||
|
2015
Q2 | $4.02M | Sell |
|
|||||
|
2015
Q1 | $14.8M | Sell |
|
|||||
|
2014
Q4 | $13.9M | Buy |
|